Twin Capital Management Inc Moderna, Inc. Transaction History

Twin Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$118.07 - $194.18 $8,855 - $14,563	-75 Reduced 0.62%	11,952 $1.41 Million
Q2 2022 Aug 02, 2022	SELL	$117.13 - $176.59 $33,616 - $50,681	-287 Reduced 2.33%	12,027 $1.72 Million
Q1 2022 May 06, 2022	SELL	$126.46 - $235.05 $9,610 - $17,863	-76 Reduced 0.61%	12,314 $2.12 Million
Q4 2021 Feb 07, 2022	SELL	$225.82 - $368.51 $51,938 - $84,757	-230 Reduced 1.82%	12,390 $3.15 Million
Q3 2021 Oct 29, 2021	SELL	$221.9 - $484.47 $94,529 - $206,384	-426 Reduced 3.27%	12,620 $4.86 Million
Q2 2021 Aug 09, 2021	SELL	$129.91 - $234.98 $738,668 - $1.34 Million	-5,686 Reduced 30.35%	13,046 $3.07 Million
Q1 2021 May 06, 2021	SELL	$109.18 - $185.98 $207,442 - $353,362	-1,900 Reduced 9.21%	18,732 $2.45 Million
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $232,916 - $601,813	-3,543 Reduced 14.66%	20,632 $2.16 Million
Q3 2020 Nov 05, 2020	SELL	$54.34 - $94.85 $10,596 - $18,495	-195 Reduced 0.8%	24,175 $1.71 Million
Q2 2020 Aug 04, 2020	BUY	$29.67 - $80.0 $723,057 - $1.95 Million	24,370 New	24,370 $1.57 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Twin Capital Management Inc with notifications on news.